About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2/3NCT00980044

Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal

Prescription opioid addiction is a growing public health problem and more pharmacologic treatments are needed because current approved medications have had limited patient acceptance (naltrexone), lim...

Lead sponsor: Michelle Lofwall•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Michelle Lofwall

Collaborators

National Institute on Drug Abuse (NIDA)

Age

18 - 55 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Addicted to opioids

Exclusion Criteria

•Any major medical or psychiatric disorder that would be contraindicated for participation

Related studies

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

NCT00792415 · Substance Withdrawal Syndrome

Opioid Withdrawal Symptoms in Critically Ill Patients

NCT03374722 · Substance Withdrawal Syndrome, Critical Illness

COMPLETEDPhase 1

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

NCT02801357 · Substance Withdrawal Syndrome, Opiate Addiction, and more

Effect of Ondansetron for Withdrawal Symptoms

NCT00695864 · Substance Withdrawal Syndrome

COMPLETEDPhase 1

Acute Withdrawal From Smoked Cocaine - 9

NCT00000292 · Cocaine-Related Disorders, Substance Withdrawal Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 5, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment53

Start dateOct 2009

Last updatedApr 5, 2017

Condition

Substance Withdrawal Syndrome

Locations shown

University of Kentucky

Lexington, Kentucky

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 5, 2017Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions